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Biomarker AUC P-value vs. aggregate
Cartilage thickness 0.60 0.008
Cartilage smoothness 0.79 0.33
Cartilage homogeneity 0.67 0.041
Cartilage volume 0.58 0.011
Cartilage curvature 0.76 0.24
uCTX-II 0.71 <0.001
Bone structure 0.77 0.075
Aggregate: All biomarkers 0.85 –
Conclusions: The complexity and heterogeneity of OA makes it unlikely
that a single marker will allow a comprehensive quantiﬁcation. Therefore,
aggregate markers based on measurements from different modalities and
targeting different anatomical structures could potentially be superior.
The results showed that the very different OA biomarkers each provided
some diagnostic ability. However, the aggregate combination marker was
superior and demonstrated the potential for multi-model markers. The
potential challenge of quantifying many markers was overcome by mainly
using fully automatic computer-based MRI markers allowing scalability to
large, multi-center studies.
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Purpose: Pain is the most prominent and disabling symptom of osteoarthri-
tis (OA). Despite its importance, much remains unknown about OA pain.
Current assessment methods for pain are subjectively evaluated by the
patients.
The gold standard for assessing joint damage is still the radiograph.
However, this method only provides a historical view of the damage, and
is rather insensitive and does not allow for the early detection of joint
damage. In addition, there are weak associations between pain severity and
radiographic change.
There is an urgent need for reliable, quantitative, and dynamic tests that
will detect early joint damage. Biomarkers, in addition to MRI, are expected
to be candidates that can detect the cartilage, bone and synovium turnover
for an objective and eﬃcient assessment of the joint damage in OA.
The present study sought to detect early-stage knee OA based on criteria
involving the presence of pain using the biomarkers.
Methods: The 46 subjects were enrolled in this study. Following the
traditional deﬁnition for OA, the subjects with the K/L 1 were diagnosed
as having an absence of OA and those with KL2 were diagnosed as having
knee OA. Pain in the knee was assessed using a visual analogue scale (VAS).
The biomarkers used were for serum collagen type II cleavage (sC2C),
synthesis of type II collagen carboxy propeptide (sCP II), hyaluronic acid
(sHA), urinary type II collagen C-telopeptide (uCTX-II/Cr), and N-terminal
crosslinking telopeptide of type I collagen (uNTx/Cr). The serum and urinary
levels of these biomarkers were applied to logarithmic transformation, and
they were adjusted for age, sex and body mass index for comparison. The
parametric comparisons used analysis of variance (ANOVA). A p<0.05 was
considered to be signiﬁcant.
Results: The 46 subjects consisted of 30 subjects with K/L 1 and 16 with
K/L 2. 16 subjects had knee pain, and remaining 30 subjects did not have
knee pain. The 30 subjects without knee pain consisted of 22 subjects with
K/L 1 and the 8 subjects with K/L 2. 8 subjects with knee pain showed
radiographic K/L 1 and, the remaining 8 showed K/L 2.
First, the subjects were divided into two groups according to the presence
or absence of a radiographic OA. No signiﬁcant differences of the sC2C,
uCTX-II/Cr and uNTx/Cr were observed between the subjects with K/L1
and those with K/L2. The sCPII in the subjects with K/L2 were signiﬁcantly
reduced in comparison to those with K/L2, while the sHA showed opposite.
Second, the subjects were divided into two groups according to the pres-
ence or absence of a knee pain. The sC2C, uCTX-II/Cr, sCPII and sHA were
signiﬁcantly increased in those with knee pain in comparison to those
without knee pain. No signiﬁcant differences of the uNTx/Cr were observed
between these two groups.
Third, the subjects were divided into four groups according to the presence
or absence of both radiographic knee OA and knee pain. The sC2C in the
subjects with K/L 1 and knee pain signiﬁcantly increased in comparison
to the subjects with K/L 1 and 2 without knee pain. The sCPII in the
subjects with K/L 1 and knee pain increased in comparison to those in
other three groups. The uCTX-II/Cr in the subjects with K/L 2 and knee pain
signiﬁcantly increased in comparison to those in the subjects with K/L 1
and 2 without knee pain. No signiﬁcant differences of the uNTx/Cr were
observed between these four groups. The sHA in the subjects with K/L 2
with and without knee pain signiﬁcantly increased in comparison to those
in the subjects with K/L 1 without knee pain.
Conclusions These results suggest that osteoarthritic knee pain in early-
stage knee OA, such as not only K/L 2 but also K/L 1, is associated with
metabolic changes revealed by these biomarkers, namely anabolic, catabolic
and inﬂammatory responses involving cartilage and probably synovium,
while it is not associated with gross radiographic changes of the knee and
how these changes trigger pain still remains unclear.
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Introduction: Standard morphometric cartilage parameters of volume and
average cartilage thickness have shown very low responsiveness to OA
progression, which limits their utility for OA clinical trials. However, a
novel automated atlas based standardized measurement method allows the
use of advance image analysis methodologies to quantify point by point
changes in cartilage thickness. The data from this point by point atlas based
process provides a more sensitive analysis of OA progression.
Objective: To evaluate the sensitivity of an atlas based standardized
measurement method to detect changes in articular cartilage thickness in
subjects with OA symptoms but no radiological evidence of OA.
Methods: The baseline, 12 month and 24 month DESS sagittal MRI knee
images of 133 subjects from the OAI progression cohort releases: 0.C.2,
1.C2, 3.C.1 were segmented to bones and articular cartilage using a fully
automated atlas based segmentation algorithm and a previously developed
anatomic atlas. All segmentations were evaluated for quality; 4 subjects
were removed due to large segmentation errors. Using the atlas deforma-
tions 3D map, all the cartilage thickness maps were mapped back to the
anatomic atlas, and were compared point by point to the atlas cartilage
thicknesses. After the thickness measurements were mapped onto the
atlas space, all cartilage measurements were compared to the baseline
measurement by a point by point subtraction. The change in thickness
values from baseline were statistically described by mean, variance and
percentiles of thickness change values for each subject and for each
cartilage plate. The quantiﬁcation was done on cMF, cLF, MT, LT, F, T,
medial WB, lateral WB and the entire tibia femoral joint (TF). The paired
KL scores of the 133 subjects and the JSN OARSI scores provided by the
OAI site (http://www.oai.ucsf.edu) were used to identify the subjects with
Table 1. The annualized change, the standard deviation of the residuals, the annualized
standard response of the mean (SRM) and the proportion of subjects that change mea-
surement from the 12 month to the 24 month visit are shown for the average cartilage
change, the standard difference of changes, and the average values of the lower 5% per-
centile of changes are shown for the different cartilage regions
*Statistically signiﬁcant form zero (p<0.05). ** are proportions statistically different from
0.5 (p<0.05)
